Showing results (231-240 of 245) with videos related to
Sort By:
Pageof 25
BMC Psychiatry|June 28, 2023
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.Neuropsychopharmacology Reports|July 1, 2020
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" projectKayo Ichihashi, Hikaru Hori, Naomi Hasegawa, et al.The International Journal of Neuropsychopharmacology|June 20, 2022
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide StudyShinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, et al.Neuropsychopharmacology Reports|November 29, 2022
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" projectHitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, et al.Asian Journal of Psychiatry|January 20, 2022
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE projectKayo Ichihashi, Yoshitaka Kyou, Naomi Hasegawa, et al.Asian Journal of Psychiatry|June 6, 2022
Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site studyHiroyuki Muraoka, Fumitoshi Kodaka, Naomi Hasegawa, et al.Journal of Clinical Psychopharmacology|May 22, 2023
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in JapanToshiaki Onitsuka, Tsuyoshi Okada, Naomi Hasegawa, et al.Psychiatry and Clinical Neurosciences|October 10, 2022
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysisTakashi Tsuboi, Yoshikazu Takaesu, Naomi Hasegawa, et al.Annals of General Psychiatry|December 25, 2022
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" projectYoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, et al.Frontiers in Psychiatry|June 3, 2022
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital CharacteristicsHikaru Hori, Norio Yasui-Furukori, Naomi Hasegawa, et al.Pageof 25